Not known Factual Statements About Healthcare News
Novo CEO pressed by Senate to cut price ranges of weight problems, diabetes medicine CEO Lars Fruergaard Jørgensen advised lawmakers the organization would take into consideration new talks with insurers concerning the listing price ranges of Wegovy and copyright should they pledge to help keep the medicines on their own formularies.Elevance lower